CliffBio

Intra-Cellular Therapies

Patent cliffs & loss of exclusivity

Small molecules for neurology

Company

AngelList URLhttps://angel.co/intra-cellular-therapies
CAGE Code3CQL3
Legal NameIntra-Cellular Therapies, Inc.
Company Operating StatusAcquired
Crunchbase URLhttps://www.crunchbase.com/organization/intra-cellular-therapies
Full Address430 E 29TH ST STE 900 NEW YORK, NY 10016 UNITED STATES
LinkedIn URLhttps://www.linkedin.com/company/intra-cellular-therapies/about/
Pitchbook URLhttps://pitchbook.com/profiles/company/55295-29

3 upcoming patent cliffs

DrugIngredientTypeCliff
  1. CAPLYTALUMATEPERONE TOSYLATESmall mol.Dec 2040
  2. CAPLYTALUMATEPERONE TOSYLATESmall mol.Dec 2040
  3. CAPLYTALUMATEPERONE TOSYLATESmall mol.Dec 2040

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.